In Entresto patent litigation with MSN Pharmaceuticals, Novartis denied leave to amend
MLex Summary: A US judge crossed out "granted" and wrote in "denied" on an order proposed by patent owner Novartis, who sought leave to add MSN Pharmaceuticals' US subsidiary Novadoz as...To view the full article, register now.
Already a subscriber? Click here to view full article